GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicover AB (OSTO:MCOV B) » Definitions » 3-Year Sharpe Ratio

Medicover AB (OSTO:MCOV B) 3-Year Sharpe Ratio : 0.67 (As of Jul. 12, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Medicover AB 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-07-12), Medicover AB's 3-Year Sharpe Ratio is 0.67.


Competitive Comparison of Medicover AB's 3-Year Sharpe Ratio

For the Medical Care Facilities subindustry, Medicover AB's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB's 3-Year Sharpe Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Medicover AB's 3-Year Sharpe Ratio falls into.


;
;

Medicover AB 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


Medicover AB  (OSTO:MCOV B) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Medicover AB 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Medicover AB's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicover AB Business Description

Traded in Other Exchanges
Address
Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, SE-102 46
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine; and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.

Medicover AB Headlines

No Headlines